NL-OMON35011
Recruiting
Not Applicable
A prospective, descriptive cohort study evaluating the prevalence and incidence of exocrine pancreatic insufficiency in patients with pancreatic cancer. - Prevalence, incidence of EPI in pancreaticcancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients who are considered for this trial:
- •\- Age \>\= 18 years.
- •\- Malignant tumours of the pancreas, distal cholangiocarcinoma and papillary tumours proven by means of cytology/histology and/or radiology.
- •\- are capable and willing to follow instructions given by the physician.
Exclusion Criteria
- •The following are considered as exclusion criteria:
- •\- Subjects who are unwilling or unable to understand and participate in the study and sign the informed consent.
- •\- Pre\-existent EPI
- •\- Pre\-existent malabsorption (short bowel disease, IBD, other)
- •\- Any known gastro\-intestinal disease or major gastrointestinal surgery that could potentially affect the intestinal absorption or metabolism of fat
- •\- Total pancreatectomy
- •\- Gastroparesis
- •\- Pregnancy/lactation
- •\- Patients who are suspected not to be reliable in participating in this study, based on the physicians experience.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
An observational, prospective cohort study to evaluate the long-term safety and efficacy of infliximab SC in patients with Ankylosing spondylitis, Rheumatoid arthritis in KoreaDiseases of the musculoskeletal system and connective tissueKCT0009223Chonnam National University Bitgoeul Hospital1,412
Recruiting
Not Applicable
An observational, prospective cohort study to evaluate the long-term safety and efficacy of infliximab SC in patients with Crohn's disease, Ulcerative colitis in KoreaKCT0009009Chung-Ang Univerisity Hospital1,500
Recruiting
Not Applicable
A prospective, explorative cohort study to assess the value of an ex vivo radiosensitivity assay as a BIOmarker of treatment Response in Oropharyngeal Cancer (BIO-ROC).oropharyngeal cancerthroat cancer10027655NL-OMON52756Erasmus MC, Universitair Medisch Centrum Rotterdam200
Not yet recruiting
Not Applicable
A prospective, explorative cohort study to identify biomarkers of treatment response in oropharyngeal cancer.NL-OMON27421Erasmus MC200
Recruiting
Not Applicable
A prospective cohort study evaluating the occurrence of short and long-term cardiovascular complications in patients hospitalized with COVID-19cardiac abnormalitiescardiac complications1008220610014523NL-OMON52303niversitair Medisch Centrum Utrecht500